Company Filing History:
Years Active: 2009-2010
Title: Winfried Ness: Innovator in Stereoselective Methods
Introduction
Winfried Ness is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stereoselective methods for producing important compounds. With a total of 2 patents, his work has implications for the production of various pharmaceutical agents.
Latest Patents
Winfried Ness holds two recent patents that showcase his expertise in stereoselective synthesis. The first patent is for a "Stereoselective method for the production of (R)-Dimepranol." This invention relates to processes for preparing a compound of the general formula (Ia), where X is a halogen atom or a pharmaceutically acceptable salt. The method involves reacting a compound of formula (II) with an optically active amino alcohol to create a first mixture of diastereomers. The second patent is for a "Stereoselective method for the production of Clopidogrel," which follows a similar process to prepare a compound of the same general formula.
Career Highlights
Winfried Ness is currently associated with Ratiopharm GmbH, a prominent company in the pharmaceutical industry. His work at Ratiopharm has allowed him to focus on innovative methods that enhance the efficiency and effectiveness of drug production. His contributions have been instrumental in advancing pharmaceutical chemistry.
Collaborations
Throughout his career, Winfried has collaborated with talented individuals such as Jiri Stohandl and Jaroslav Frantisek. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Winfried Ness is a distinguished inventor whose work in stereoselective methods has made a significant impact in the pharmaceutical field. His patents reflect his commitment to advancing drug production techniques, and his collaborations further enhance his contributions to the industry.